Henry Schein Restructures Leadership as Three Veteran Executives Move to Advisory Roles
By Dr. Andrea Joy Smith
Henry Schein will replace its Executive Management Committee with a new leadership team and transition three longtime executives into senior advisory roles.
This Article is Sponsored by Dental Media Now
MELVILLE, N.Y., July 30, 2026, (DrAndreaJoySmith.com) — Healthcare products and technology company Henry Schein has announced a new leadership structure that includes the creation of the Henry Schein Leadership Team.
Recent News about Dr. Andrea Joy Smith
•
Recent News about Dr. Andrea Joy Smith •
The new group will replace the company’s Executive Management Committee and oversee the development and execution of Henry Schein’s strategic priorities.
Latest Blogs
•
Latest Blogs •
Henry Schein will also integrate its global supply chain organization with its global distribution group. The company says the changes are intended to simplify operations, strengthen collaboration and accelerate decision-making.
Dental Media Now
•
Dental Media Now •
Michael S. Ettinger, Executive Vice President and Chief Operating Officer; Mark E. Mlotek, Executive Vice President and Chief Strategy Officer; and James Mullins, Senior Vice President of Global Supply Chain, will transition out of their current positions effective Oct. 30. All three executives will become senior advisors to the company beginning Oct. 31.
“I am pleased to announce a new leadership structure at Henry Schein that reflects an important evolution of our organization designed to help Henry Schein become simpler, prioritize and make decisions faster, better execute on our priorities, and become an even more customer-centric organization. By bringing our supply chain teams closer to the customers served by our distribution businesses and enabling direct management of our corporate functions, these changes will further expedite prioritization, accelerate decision making, and advance efforts to simplify our operating model. Taken together, these changes will continue helping improve our Company and position Henry Schein for even greater success. Over their decades with Henry Schein, the wide-ranging impact made by Michael, Mark, and Jim upon our Company, the healthcare industry, and patient health globally is impossible to quantify. Through his strategic vision and forging of partnerships over 30+ years, Mark played an integral role in growing Henry Schein from a small, privately-held mostly dental mail-order company into a multi-billion dollar public company that is the world’s largest provider of health care products, services, and technology platforms to office-based health care professionals. Similarly, I want to recognize Michael and Jim for helping build Henry Schein’s global corporate, legal, and supply chain infrastructure and, together, developing a world class team that today stands as a true competitive advantage. In their new senior advisory roles, we are fortunate to continue benefiting from their invaluable experience, insights, and strategic guidance as we execute our strategy and position the Company for continued success. Each of Michael, Mark, and Jim fully embody the best of our Team Schein Values, and have poured love, passion, and joy into their every initiative and interaction. I am particularly grateful to Michael and Mark for their instrumental support in my own onboarding process. On behalf of Team Schein, we thank Michael, Mark, and Jim for their exceptional leadership, partnership, and immeasurable contributions over the years,” said Fred Lowery, Chief Executive Officer of Henry Schein.
Ettinger, Mlotek and Mullins have more than 100 years of combined experience with Henry Schein.
“Henry Schein owes a debt of gratitude to Michael, Mark, and Jim for the significant impact of their contributions to Henry Schein’s growth across more than 100 years of combined experience with the Company, during which they have each served as pillars for the organization whose unique vision, dedication, and authentic reflection of Henry Schein’s values helped to create the tremendous platform upon which we continue to build,” said William K. Daniel, Chairman of the Henry Schein Board of Directors.
“Their outstanding judgment, strategic perspective, and unwavering dedication have made an extraordinary impact upon Henry Schein. It was a privilege to serve alongside Mark on the Board, and we are deeply grateful to Mark and Michael for their enduring contributions to our Board, the Company’s leadership team, and our stakeholders,” said Philip A. Laskawy, Director and former Lead Director of the Henry Schein Board of Directors.
Henry Schein provides healthcare products, services and technology platforms to dental and medical practices, laboratories, government agencies and institutional healthcare facilities. The company operates in 34 countries and territories and reported $13.2 billion in sales in 2025.
For more information, visit www.henryschein.com.
Source: Henry Schein, Inc.
